iSERA Lifesciences Approves Allotment of 1.62 Crore Shares via Share Swap
iSERA Lifesciences Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 5:31 pm
iSERA Lifesciences Approves Allotment of 1.62 Crore Shares via Share Swap On 1st Oct'26, iSERA Lifesciences Limited approved the preferential allotment of 1,61,82,800 equity shares of face value Rs. 10 each at an issue price of Rs. 48.20 per share (including Rs. 38.20 share premium). The issuance, executed on a 1:1 share swap basis for shares of iSERA Biological Limited, spans 196 promoter and non-promoter allottees. Consequently, the company's paid-up equity share capital expanded from 84,08,972 shares to 2,45,91,772 shares.
Original exchange filing (PDF)
More announcements from iSERA Lifesciences Ltd
- Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Administrative Warning Letter received .... 路 15 Nov 2026
- Dissemination of Warning Letter of SEBI 路 12 Nov 2026
- We hereby submit the revised un-Audited Financial result for Half year ended September 2026 under regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 05 Nov 2026
- We hereby submit that pursuant to Regulation 15(2) of SEBI (LODR) Regulations, 2015, the compliance with the corporate governance provisions as specified in Regulations 17, 18, 19, 20, .... 路 04 Nov 2026
- We hereby submit the Un-Audited Financial Result for the quarter and half yearly ended September 2026 路 04 Nov 2026
- Outcome of the Board Meeting held today on 4th November 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 04 Nov 2026
- Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Un-Audited Financial .... 路 04 Nov 2026
- Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Continual Disclosure consequent to Preferential Allotment of .... 路 09 Oct 2026
